Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

NCT00058084 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

NIH

Sponsor class

Conditions

Adenocarcinoma of the Prostate
Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG: ixabepilone
DRUG: mitoxantrone hydrochloride
DRUG: prednisone

Sponsor

National Cancer Institute (NCI)